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Variants of subtilisin BPN’ that possess improved specificity towards isoleucine compared with alanine at the P4 position of small peptide substrates, 
were analysed for their ability to bind chymotrypsin inhibitor 2. The binding of the inhibitor with isoleucine (wild-type) and with alanine as the 
P4 residue parallels the hydrolysis of tetrapeptide substrates. There is a linear relationship between the free energy of binding of the transition state 
of the substrate and the free energy of binding of the inhibitor with a slope. of 2.0. The data suggest hat the inhibitor uses predominantly ground 
state rather than transition state binding energy. 
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1. INTRODUCTION 
Subtilisin BPN’ is a serine-class endoprotease from 
Bacillus amyloliquefacierzs [l], which binds substrates 
with a rather broad specificity. The enzyme has two 
binding pockets, S, and S,, and its substrate specificity 
is determined mainly by the interaction of the P, and P4 
amino acid side chains of the substrate with these pock- 
ets (nomenclature of the binding sites as defined by 
Schechter and Berger+ [2]). The specificity towards both 
the P, and P4 residues of small oligopeptide substrates 
can be substantially increased by altering amino acid 
side chains in the S1 and S4 pocket, respectively [3-6], 
e.g. increasing the size of the S4 pocket by shortening 
amino acid residues can improve the specificity of sub- 
tilisin towards tetrapeptides with large hydrophobic P4 
residues by up to 200-fold. However, subtilisin has a 
total of at least eight binding subsites [7,8] and it is still 
speculation as to whether the binding of longer peptides 
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or whole proteins is similarly affected by these muta- 
tions. Inspection of the high-resolution crystal structure 
of the complex between subtilisin BPN’ and chymotryp- 
sin inhibitor 2, a potent polypeptide inhibitor of chy- 
motrypsin and subtilisin, reveals that the P, and P4 res- 
idues together account for only 48%, and the Pi,P,,P, 
and P4 residues for 65%, of all < 4 A contacts to subtil- 
isin [7]. In fact, it has been reported that the catalytic 
efficiency of subtilisin BPN’ for the hydrolysis of small 
peptide substrates is sensitive to the bulkiness of the P4 
side chain, while binding of Streptomyces subtilisin in- 
hibitor is not [9]. In this work, we analyse wild-type and 
four variants of subtilisin BPN’ that carry different 
amino acid replacements in the S4 pocket, for their ca- 
pacity to bind wild-type C12 (isoleucine at the P, posi- 
tion) and a mutant C12 in which 156 has been replaced 
by alanine (156A C12; alanine at the P, position). The 
corresponding binding constants are compared with the 
catalytic constants for the hydrolysis of tetrapeptide 
substrates. 
2. MATERIALS AND METHODS 
Restriction enzymes and other DNA-modifying enzymes were pur- 
chased from Boehringer Mannheim Corporation, Pharmacia or New 
England Biolabs. Oligonucleotides were synthesised on an Applied 
Biosystems ABI 380B oligonucleotide synthesiser. All other reagents 
were of analytical grade. 
The vector pCI2, used for the mutagenesis and expression of the C12 
gene, was constructed by subcloning the 328 bp BgflI/HindIII frag- 
ment from the plasmid pPO1 (F. Poulsen, pers. comm.), carrying a T7 
RNA polymerase $10 promoter, a ribosome binding site and the C12 
gene, into the multiple cloning site of pTZ18U [lo]. In the resulting 
pCI2 plasmid, the codon for isoleucine 56 was replaced by that of 
alanine in an inverse polymerase chain reaction [l l] using the primers 
S-CATGGTACAGCTGTCCCCAC-3’ and S-GAATATCGGATCG- 
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ACCGCGTCCGCCTCTTT-3’. The constructs were verified by se- 
quencing [12] of the entire coding sequence. 
Wild-type and the 156A mutant C12 were expressed in, and purified 
from Escherichia coli strain TG2 harbouring the appropriate pCI2 
plasmid. Cells were ruptured by sonication and the nucleic acids were 
precipitated from the resulting homogenate by addition of 1% (w/v) 
polyethylenimine. Following centrifugation at 18,000 x g for 10 min, 
the C12 protein was precipitated from the supematant by addition of 
65% ammonium sulphate andcollected by centrifugation at 18,000 x g 
for 30 min. The pellet was dissolved in 50 mM Tris-HCI at pH 8.6 and 
dialysed against the same buffer. Since C12 does not bind to anion- 
exchange resin under these conditions, a partial purification was ef- 
fected by binding contaminating proteins to DEAE-Trisacryl (1 ml 
resin/20 ml solution). The solution was centrifuged at 4,000 x g for 10 
min and the supematant applied to a HiLoad 26160 Superdex G75 
column (Pharmacia) equilibrated with a buffer of 50 mM Tris-HCl at 
pH 8.6. C12 eluted after 200 ml at a flow rate of 2.6 ml . min-‘. 
Fractions containing pure protein were pooled, dialysed against water, 
lyophilised and stored at -7O“C. A molar extinction coefficient of 
6965 M-’ cm-’ (S. Jackson, personal communication) was used for 
the determination of wild-type and 156A C12 concentrations. The 
construction, expression, and purification of the different subtilisin 
variants have been reported earlier [5,6]. 
Slow binding kinetics were measured as described previously [13] 
using a range of inhibitor concentrations (l-25 nM) and an enzyme 
concentration of approximately 0.25 nM. Data from each curve at 
different inhibitor concentrations were fitted to Equation 1 
A = v,t + (v, - v,) (1 - exp(-k,,,,t))lk,,, + A, (1) 
where A is the absorbance, A, is the initital absorbance, v, is the initial 
rate, v, is the fmal steady-state rate, and /c,,~ is the apparent first-order 
rate constant for the transition to the steady-state rate. The association 
rate constant, k,,, was determined from a plot of kobr versus the 
inhibitor concentration. The inhibition constant, Ki, was determined 
from a plot of (v, - v,)Iv, versus the inhibitor concentration, and k,, 
the dissociation rate constant, was calculated according to 
k,fl= k,, x 4 [13]. 
3. RESULTS AND DISCUSSION 
In the crystal structure of the subtilisinCI2 complex 
[7,14], close-range intermolecular contacts to the P4 res- 
idue of C12 are made by residues Y104,1107, and L126 
in the S, pocket of subtilisin (Fig. 1). Replacement of 
Y 104 by alanine, 1107 by glycine, L126 by alanine, and 
UZU El28 L lEU El26 L 
he lx I +9 El07 El04 
Table I 
Binding constants of wild-type and 156A C12 to different subtilisin 
variants and kinetic constants for the hydrolysis of small peptide 
substrates= 
Subtilisin 
variant 
Ki k k Lb 
(x lo-‘* M)$,?$ (x lo”-“6 s-‘) (mM) 
kcatKnb 
(x lo5 
M-1 . s-I) 
Wild-type 
Y104A 
1107G 
L126A 
1107G/L126V 
Wild-type CI2/Ile at P4 site 
1.2 3.5 4.4 0.08 3.75 
2.2 3.4 7.7 0.07 1.01 
1.1 9.1 9.7 0.04 2.2 
3.4 10.3 35 0.04 0.36 
6.4 1.4 8.9 0.05 0.07 
Wild-type 1.2 
Y104A 20.6 
1107G 16.2 
L126A 15.7 
1107lL126V 49 
156ACIZAla at P4 site 
3.1 3.8 0.15 
3.3 67.2 1.62 
8.8 140 0.23 
19.1 300 0.84 
nd’ nd” 0.62 
2.33 
0.014 
0.014 
0.013 
0.0013 
“Slow binding kinetics were measured as described in section 2. 
‘Steady-state kinetic constants for the hydrolysis of the substrate suc- 
cinyl-X-Ala-Pro-Phe-pNA, where X is the P4 residue. Data taken 
from [5,6]. 
‘Not determined. 
the construction of the double mutant 1107G/L126V 
each increase the size of the S4 pocket, thereby improv- 
ing the specificity of the protease towards large hydro- 
phobic P4 residues. The kinetic parameters of wild-type 
and the mutant subtilisins for the hydrolysis of small 
peptides have been determined previously [5,6] and are 
included in Table I to allow comparison with the results 
found in this work. All four mutant subtilisins possess, 
to various degrees, increased specificity towards isoleuc- 
ine compared with alanine at the P4 position of the 
tetrapeptides ubstrates. 
Wild-type and 156A C12 were treated as slow-binding 
inhibitors, since the attainment of steady-state nzyme 
activity was observed over a time period of several min- 
utes, and the data fitted to Equation 1, the integrated 
El04 
Fig. 1. Stereographic representation of the S, binding pocket of subtilisin BPN’. The view is into the pocket. The P, residue of C12 (156) and the 
residues Y104, 1107, and L126 are shown. 
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Fig. 2. Comparison of the free energy of binding of the transition state 
of substrates to subtilisin variants with the binding energy of mutants 
of C12 with the same amino acid in the P4 subsite. The slope of the 
straight line is 2.0. Squares, AG values for alanine at the P4 position 
of the substrate or inhibitor; circles, AG values for isoleucine at the P4 
position of the substrate or inhibitor. 
rate equation describing substrate hydrolysis in the 
presence of a slow-binding inhibitor [13]. The binding 
constants for wild-type and 156A C12 to the various 
subtilisin variants are summarized in Table I. Wild-type 
C12 (having an isoleucine at the P, position) binds 
equally well to wild-type and 1107G subtilisin, but pos- 
sesses omewhat higher Ki values for binding to Y 104A, 
L126A, and the 1107G/L126V double-mutant subtilisin. 
Further, there is an apparent correlation between the Ki 
values of wild-type C12 and the k,JK,,, values for the 
hydrolysis of tetrapeptide substrates: the Ki values in- 
crease with decreasing catalytic efficiency of the subtili- 
sin variants. However, no apparent correlation was 
found between the Ki and X, or between the Ki and kc,, 
values alone. Introducing an alanine residue at the P4 
position of C12 has no effect on the binding of the 
inhibitor to wild-type subtilisin, a similar result has also 
been reported recently for the binding of Streptomyces 
subtilisin inhibitor [15], but results in substantially in- 
creased Ki values for all four mutants of subtilisin. 
Changes in Ki values are mainly due to increased disso- 
ciation rate constants, while k,, values remain virtually 
unaffected. Again, there is an apparent correlation be- 
tween Ki and k,JK, values, but not between Ki and K, 
or & and k,,, values. 
The tight binding of C12 to subtilisin and the appar- 
ent correlation between K and k,JK,,, values suggest 
that the inhibitor uses both ground state and transition 
state binding energy. Free energy values were calculated 
for the kinetic parameters k,JK,,, and Ki [ 161 for isoleuc- 
ine as well as alanine at the P4 position using the expres- 
sions 
AG(k,,IK,,J = RT ln(k,,/Kd 
and 
(2) 
AG(KJ = -RT ln(KJ (3) 
Changes in energy measured by Equation 2 should be 
the same as changes in the binding energy of the transi- 
tion state of the substrate to the enzyme [16] whereas 
Equation 3 gives the binding energy of the inhibitor. As 
shown in Fig. 2, there is a linear relationship between 
AG(k,,JK,J and AGQYJ for wild-type and all subtilisin 
variants with isoleucine and alanine as P4 residue of the 
substrate/inhibitor. The slope of the line is 2.0, suggest- 
ing that, as far as substrate occupancy is concerned, C12 
uses only part of the available transition state binding 
energy. Inhibitor binding is, therefore, less sensitive to 
mutation than is the catalytic efficiency (if the Ki value 
would be similarly affected as the k,,/K,,, value, then the 
slope of the line would be 1). This result supports earlier 
findings from crystal structures of protease-inhibitor 
complexes, which indicate that the inhibited complex is 
close to a Michaelis complex [9,16,17]. 
For some mutants of subtilisin, changes in the cata- 
lytic efficiency result, to a certain degree, from struc- 
tural changes on mutation that are transmitted from the 
S4 pocket to the active site [5,6]. However, this is not the 
case for the Y 104A mutant subtilisin, and the influence 
of amino acid replacements in the S, pocket on the 
structure of the S, pocket or active site varies for the 
other subtilisin variants [5,6]. Thus, the binding of in- 
hibitors, such as C12, and probably also the hydrolysis 
of long peptide substrates, seem to be affected by 
changes in the S, pocket of subtilisin in a similar manner 
to the hydrolysis of small tetrapeptide substrates. On 
the basis of the above data, we conclude that the binding 
of polypeptide inhibitors to subtilisin BPN’ and also the 
activity of the enzyme towards long peptide or protein 
substrates can be remodelled by altering the P4 residue 
and/or the structure of the S, pocket. 
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